Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 7,500 | |||
25 mg | 在庫あり | ¥ 11,000 | |||
50 mg | 在庫あり | ¥ 18,000 | |||
100 mg | 在庫あり | ¥ 29,500 | |||
200 mg | 在庫あり | ¥ 43,500 | |||
500 mg | 在庫あり | ¥ 73,000 |
説明 | Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis. |
別名 | CGP-4244, CGP42446A, Zoledronate, CGP 42446, ZOL 446, Zometa |
分子量 | 272.09 |
分子式 | C5H10N2O7P2 |
CAS No. | 118072-93-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1.1eq. NaOH: 13.6 mg/mL (50 mM)
H2O: 1.6 mg/ml(5.88 mM), Sonication is recommended.
0.1M NAOH: 12.5 mg/ml(45.94 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zoledronic Acid 118072-93-8 Apoptosis Autophagy Cell Cycle/Checkpoint Rho activity anti-cancer CGP-4244 Inhibitor CGP-42446 CGP42446A bisphosphonate Zoledronate CGP 4244 inhibit anti-resorptive CGP 42446 CGP4244 osteoclast ZOL446 ZOL 446 osteoporosis CGP42446 Zometa ZOL-446 inhibitor